Evoke Pharma (NASDAQ:EVOK) Stock Price Passes Below 200 Day Moving Average of $0.72

Evoke Pharma, Inc. (NASDAQ:EVOK)’s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.72 and traded as low as $0.55. Evoke Pharma shares last traded at $0.55, with a volume of 3,098 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Evoke Pharma in a research note on Thursday. They issued a “sell” rating for the company.

Evoke Pharma Stock Performance

The firm has a market capitalization of $4.69 million, a PE ratio of -0.30 and a beta of 0.36. The business’s fifty day simple moving average is $0.49 and its 200-day simple moving average is $0.72.

Evoke Pharma (NASDAQ:EVOK) last posted its earnings results on Tuesday, May 14th. The specialty pharmaceutical company reported ($0.17) earnings per share for the quarter. The company had revenue of $1.74 million for the quarter. Evoke Pharma had a negative net margin of 116.75% and a negative return on equity of 4,908.09%.

Evoke Pharma Company Profile

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.